Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System

IMPORTANCE: Management of high-risk non–muscle-invasive bladder cancer (NMIBC) represents a clinical challenge due to high failure rates despite prior bacillus Calmette-Guérin (BCG) therapy. OBJECTIVE: To describe real-world patient characteristics, long-term outcomes, and the economic burden in a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Stephen B., Howard, Lauren E., Foster, Meagan L., Klaassen, Zachary, Sieluk, Jan, De Hoedt, Amanda M., Freedland, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013821/
https://www.ncbi.nlm.nih.gov/pubmed/33787908
http://dx.doi.org/10.1001/jamanetworkopen.2021.3800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013821/
https://www.ncbi.nlm.nih.gov/pubmed/33787908
http://dx.doi.org/10.1001/jamanetworkopen.2021.3800

Ejemplares similares